## CBRE: CBRE Group Inc - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($151.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Micron Technology To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Monday**
- Source: Benzinga | 20251215T132951 | Somewhat-Bullish | Relevance: 73%
- This article details ten analyst forecasts for various companies, highlighting significant upgrades and price target changes. Notably, Wedbush boosted Micron Technology's price target from $220 to $300, maintaining an Outperform rating. Other companies like Hershey Co, Ashland Inc, CBRE Group Inc, Hilton Hotels Corporation, DBV Technologies SA â€“ ADR, Bristol-Myers Squibb Co, Akamai Technologies Inc, and Merck & Co Inc also received positive analyst revisions.

**2. Jones Lang LaSalle Incorporated $JLL Shares Acquired by EdgePoint Investment Group Inc.**
- Source: MarketBeat | 20251214T081036 | Neutral | Relevance: 64%
- EdgePoint Investment Group Inc. significantly increased its stake in Jones Lang LaSalle (NYSE:JLL) during the second quarter, now owning 2,221,528 shares valued at $568.2 million, making it their 12th largest holding. Wall Street analysts maintain a "Moderate Buy" consensus with an average target price of $342.14, and JLL recently exceeded earnings expectations, reporting an EPS of $4.50 against an anticipated $4.24. Despite a recent insider stock sale by CEO Christian Ulbrich, institutional ownership remains high at 94.80%.

**3. Thrivent Financial for Lutherans Sells 520,925 Shares of Cushman & Wakefield PLC $CWK**
- Source: MarketBeat | 20251215T120952 | Neutral | Relevance: 61%
- Thrivent Financial for Lutherans reduced its stake in Cushman & Wakefield PLC by 9.5% in the second quarter, selling 520,925 shares and retaining 4,943,961 shares valued at $54.73 million. Cushman & Wakefield reported strong Q2 earnings, beating analyst expectations with $0.29 EPS and $2.61 billion in revenue, and provided optimistic FY2025 guidance. Despite mixed analyst ratings, the company trades near $15.28 with a market cap of $3.54 billion.

**4. Bamco Inc. NY Increases Stock Holdings in Jones Lang LaSalle Incorporated $JLL**
- Source: MarketBeat | 20251213T110951 | Somewhat-Bullish | Relevance: 56%
- Bamco Inc. NY has increased its stock holdings in Jones Lang LaSalle Incorporated (NYSE:JLL) by 9.9% in the second quarter, now owning 518,364 shares valued at $132.6 million. Other major institutional investors have also significantly increased their stakes, leading to 94.8% institutional ownership. Despite recent insider selling by CEO Christian Ulbrich, analysts maintain a "Moderate Buy" rating with a consensus price target of $342.14, following strong earnings that topped estimates.

**5. Westwood Holdings Group Inc. Grows Stock Holdings in Sunstone Hotel Investors, Inc. $SHO**
- Source: MarketBeat | 20251215T140912 | Neutral | Relevance: 55%
- Westwood Holdings Group Inc. increased its stake in Sunstone Hotel Investors, Inc. by 10.7% in Q2 2025, now owning 3,961,174 shares valued at $34.38 million. Sunstone Hotel Investors reported strong Q3 earnings, beating analyst estimates with EPS of $0.17 and revenue of $229.3 million, and announced a quarterly dividend of $0.09 per share. The company currently holds a consensus "Hold" rating from analysts with an average target price of $9.14.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Keefe, Bruyette | $185 | $168 | +10% |
| 2025-12-02 | Barclays | $190 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Keefe, Bruyette | up | Outperform |
| 2025-12-02 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.2%)
- Blackrock Inc.: 9.3% (-1.2%)
- State Street Corpora: 4.7% (+0.8%)
- Principal Financial : 3.2% (+9.3%)
- FMR, LLC: 2.8% (+89.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +4.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.3B |
| Beta | 1.34 |
| 52W Range | $108.45 - $171.00 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 21.6 |
| Current P/E | 25.1 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.3% to 1.6% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 53. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.59% (CS: 43) | Neutral |
| RSI_14 | 52.8 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.105x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $158.87
- **Stop Loss:** $151.53 (4.6% risk)
- **Target:** $166.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 136
- **Position Value:** $21,606.32
- **Portfolio %:** 21.61%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-12 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.46 | $1.61 | +10.6% |
| 2025Q2 | $1.07 | $1.19 | +11.2% |
| 2025Q1 | $0.76 | $0.86 | +12.7% |
| 2024Q4 | $2.23 | $2.32 | +3.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*